KISIMA-01
Showing 1 - 25 of 879
Pancreatic Ductal Adenocarcinoma Trial in New York (VSV-GP154, ATP150, ATP152)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- VSV-GP154
- +3 more
-
New York, New YorkNYU Langone Health
May 4, 2023
Porto-Venous Radiomics in Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- Non-Interventional
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Jan 17, 2023
Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))
Not yet recruiting
- Healthy
- TR-01-XRR (1)
- +6 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Feb 3, 2023
Outcome of GI Cancer in NCKUH
Completed
- Collection of Real-world Data in a Single Institute
-
Tainan, Taiwan
- +1 more
Jan 17, 2023
Email Reminders on No-Show Rates for Appointments inUrology
Recruiting
- No-Show Patients
- Reminder Systems
- E-Mail Reminder
-
Caba, ArgentinaHospital Italiano de Buenos
Nov 2, 2023
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
Joint Pain Trial in Mumbai, Nashik, Panvel (E-PR-01 (Low dose), E-PR-01 (High Dose), Placebo)
Not yet recruiting
- Joint Pain
- E-PR-01 (Low dose)
- +2 more
-
Mumbai, Maharashtra, India
- +3 more
Apr 24, 2023
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
Active, not recruiting
- Hemophilia B
- AAV5-hFIX
-
Berlin, Germany
- +5 more
Jan 17, 2023
How do Perceptions of Coronavirus Disease Risk Influence Health
Recruiting
- Pregnancy Related
-
Vancouver, British Columbia, Canada
- +1 more
Jan 9, 2023
Cancer Patient Perspectives During COVID-19
Active, not recruiting
- Breast Cancer
-
Aurora, ColoradoColorado Research Center
Nov 17, 2022
Adverse Events Trial in United States (Irrisept, Standard of Care)
Completed
- Adverse Events
- Irrisept
- Standard of Care
-
Tucson, Arizona
- +16 more
May 4, 2022
Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+
Not yet recruiting
- Breast Cancer
- (no location specified)
Aug 21, 2023
Hernia, Inguinal Trial in Salt Lake City (local anaesthetic injection)
Recruiting
- Hernia, Inguinal
- local anaesthetic injection
-
Salt Lake City, UtahTodd Bertoch
Apr 14, 2023
Telomere Biology Disorders With Bone Marrow Failure Trial in Cincinnati (EXG34217)
Not yet recruiting
- Telomere Biology Disorders With Bone Marrow Failure
- EXG34217
-
Cincinnati, OhioCincinnati Children's Hospital
May 18, 2023
LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1
Active, not recruiting
- Spinal Cord Injuries
- Magnetic Resonance Imaging (MRI)
-
Los Angeles, California
- +5 more
Aug 2, 2023
Psychological Status ofPatient Over 75 Years Old in Oncology
Not yet recruiting
- Depression
-
Trévenans, FranceHôpital Nord Franche-Comté
Dec 28, 2022
Professional Bladder Cancers and the Profession of Painter
Completed
- Bladder Cancer
-
Brest, France
- +5 more
Jul 6, 2023
Inflammation Eye, Pain, Postoperative, Cataract Trial in United States (Dexamethasone Ophthalmic Suspension, Vehicle of OCS-01)
Not yet recruiting
- Inflammation Eye
- +2 more
- Dexamethasone Ophthalmic Suspension
- Vehicle of OCS-01
-
Inglewood, California
- +11 more
Nov 7, 2023
Fabry Disease Who Received Lentiviral Gene Therapy in Study
Enrolling by invitation
- Fabry Disease
- Safety and Efficacy Assessments
-
Melbourne, Parkville VIC, Australia
- +2 more
Oct 5, 2022
Clinical Performance Evaluation of T-TAS®01 HD Chip
Recruiting
- Thrombocytopenia
- T-TAS 01 HD Assay
-
San Francisco, California
- +5 more
Oct 11, 2023
Fatigue Trial in Nerul, Jaipur (E-OJ-01, Microcrystalline cellulose)
Not yet recruiting
- Fatigue
- E-OJ-01
- Microcrystalline cellulose
-
Nerul, Maharashtra, India
- +1 more
Nov 22, 2022